Davita Healthcare Partners (DVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 3,294,683 | 3,263,590 | 3,186,722 | 3,070,555 | 3,145,747 |
| Cost of Goods | 2,225,372 | 2,151,875 | 2,142,299 | 2,078,976 | 2,138,369 |
| Gross Profit | 1,069,312 | 1,111,715 | 1,044,423 | 991,579 | 1,007,379 |
| Operating Expenses | 504,321 | 577,712 | 538,324 | 508,710 | 617,838 |
| Operating Income | 565,362 | 534,878 | 506,398 | 483,845 | 389,909 |
| Other Income | -151,629 | -161,444 | -134,958 | -112,059 | -100,842 |
| Pre-tax Income | 413,733 | 373,434 | 371,440 | 371,786 | 289,067 |
| Income Tax | 64,488 | 77,674 | 71,688 | 65,806 | 58,495 |
| Net Income Continuous | 349,245 | 295,760 | 299,752 | 305,980 | 230,572 |
| Minority Interests | 89,916 | 81,072 | 77,076 | 66,331 | 79,907 |
| Net Income | $259,329 | $214,688 | $222,676 | $239,649 | $150,665 |
| EPS Basic Total Ops | 3.17 | 2.56 | 2.56 | 2.73 | 1.68 |
| EPS Basic Continuous Ops | 0.55 | 3.53 | 3.45 | 3.49 | -0.36 |
| EPS Diluted Total Ops | 3.08 | 2.50 | 2.50 | 2.65 | 1.64 |
| EPS Diluted Continuous Ops | 0.53 | 3.45 | 3.37 | 3.38 | -0.35 |
| EPS Diluted Before Non-Recurring Items | 2.24 | 2.59 | 2.59 | 2.38 | N/A |
| EBITDA(a) | $739,464 | $721,892 | $682,059 | $670,928 | $585,186 |